Answers are grounded in this paper and cite their sources.
The effectiveness and prolonged action of low-dose neuroprotection with Cortexin 20 mg (10 + 10, morning, noon, daily i / m for ten days) is studied, quarterly, throughout the year, in patients with chronic cerebral ischemia, with moderate cognitive impairment . Ключевые слова: хроническая ишемия головного мозга, когнитивные нарушения, кортексин, нейропротекция.
No takes yet. Share an insight, caveat, or question.
Evzelman et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: